Plain-English translation of NCT04427384 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study tracks patients who have received GammaTile radiation implants — small, permanent devices placed in the brain immediately after tumor removal surgery. Researchers will follow your recovery over five years to understand how well this treatment controls the tumor, how it affects quality of life, and what side effects patients experience. This is the first large study to collect real-world outcomes from people treated with this specific radiation approach.
Brain tumor surgery is challenging, and doctors want to find the safest and most effective ways to prevent tumors from coming back after removal. This treatment combines surgery with immediate radiation delivered directly to the surgical site, and researchers need to understand whether this approach offers benefits over standard treatments and what risks patients should know about.
You likely qualify if…
You likely don't qualify if…
You will have already received the GammaTile implants as part of your brain tumor surgery. After that, you'll return for follow-up visits at 1, 3, 6, 9, 12, 18, and 24 months, then every 6 months for up to 5 years total. At these visits, doctors will check your recovery through imaging scans, ask about your quality of life and memory, and watch for any side effects from the surgery or radiation implant.
AI-generated summary from trial data · Aug 15, 2026 · Not medical advice
United States